CASI Pharmaceuticals, Inc.

The momentum for this stock is not very good. CASI Pharmaceuticals, Inc. is not a good value stock. CASI Pharmaceuticals, Inc. is a mediocre stock to choose.
Log in to see more information.
CASI Pharmaceuticals, Inc. is a biopharmaceutical company focused on the acquisition, development an...
CASI Fundamental Data by TradingView

News

CASI PHARMACEUTICALS TO PARTICIPATE IN THE 2024 H.C. WAINWRIGHT GLOBAL INVESTMENT CONFERENCE
CASI PHARMACEUTICALS TO PARTICIPATE IN THE 2024 H.C. WAINWRIGHT GLOBAL INVESTMENT CONFERENCE

PR Newswire CASI PHARMACEUTICALS TO PARTICIPATE IN THE 2024 H.C. WAINWRIGHT GLOBAL INVESTMENT CONFERENCE CASI PHARMACEUTICALS TO PARTICIPATE IN THE 2024 H.C. WAINWRIGHT GLOBAL INVESTMENT CONFERENCE PR Newswire...\n more…

CASI Pharmaceuticals (NASDAQ:CASI) Stock Passes Above 200-Day Moving Average of $4.46
CASI Pharmaceuticals (NASDAQ:CASI) Stock Passes Above 200-Day Moving Average of $4.46

Ticker Report Shares of CASI Pharmaceuticals, Inc. (NASDAQ:CASI - Get Free Report) crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $4.46 and traded as...\n more…

CASI Pharmaceuticals (NASDAQ:CASI) Announces Earnings Results, Beats Estimates By $0.11 EPS
CASI Pharmaceuticals (NASDAQ:CASI) Announces Earnings Results, Beats Estimates By $0.11 EPS

Ticker Report CASI Pharmaceuticals (NASDAQ:CASI - Get Free Report) announced its earnings results on Friday. The biotechnology company reported ($0.52) EPS for the quarter, topping analysts' consensus estimates of...\n more…

Short Interest in CASI Pharmaceuticals, Inc. (NASDAQ:CASI) Declines By 6.9%
Short Interest in CASI Pharmaceuticals, Inc. (NASDAQ:CASI) Declines By 6.9%

Ticker Report CASI Pharmaceuticals, Inc. (NASDAQ:CASI - Get Free Report) was the recipient of a large decrease in short interest in July. As of July 31st, there was short interest totalling 202,600 shares, a...\n more…

Casi Pharmaceuticals files to sell 3M ordinary shares for holders.
Casi Pharmaceuticals files to sell 3M ordinary shares for holders.

SeekingAlpha.com: All News Stay up to date on Casi Pharmaceuticals (CASI) with the latest offer and sale filings.\n more…

Casi Pharmaceuticals files to sell 3M ordinary shares for holders
Casi Pharmaceuticals files to sell 3M ordinary shares for holders

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…